FDA Approved Cotellic™ (cobimetinib) for the Treatment of People with BRAF V600E or V600K Mutation-Positive Unresectable or Metastatic Melanoma.
TAGRISSO™ (AZD9291) approved by the US FDA for patients with EGFR T790M mutation-positive metastatic non-small cell lung cancer
NEW Drugs AND EXPANDED COVERAGES
Below are postings for new drugs and indications you should be aware of. Please refer to the links below for announcements and details.